Last reviewed · How we verify
Xilonix plus Onivyde and 5FU
At a glance
| Generic name | Xilonix plus Onivyde and 5FU |
|---|---|
| Also known as | interleukin-1-alpha antagonist |
| Sponsor | Andrew Hendifar, MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |